Skip to main content
. 2026 Oct 21;13:1881009. doi: 10.3389/fcvm.2026.1881009

Figure 2.

Four scatter plots labeled A through D display correlations between CARMN and cardiac biomarkers or function indicators. Panel A shows a negative correlation between CARMN and cTnI (r equals negative 0.623, p less than 0.001). Panel B shows a negative correlation between CARMN and CK-MB (r equals negative 0.729, p less than 0.001). Panel C depicts a negative correlation between CARMN and Myo (r equals negative 0.747, p less than 0.001). Panel D displays a positive correlation between CARMN and LVEF (r equals 0.672, p less than 0.001). Each plot contains dots representing individual data points with fitted trend lines.

Correlation analysis of serum CARMN expression levels and myocardial injury markers. (A) The expression level of CARMN was significantly negatively correlated with cTnI (r = −0.623, P < 0.001). (B) The expression level of CARMN was significantly negatively correlated with CK-MB (r = −0.729, P < 0.001). (C) The expression level of CARMN was significantly positively correlated with Myo (r = −0.762, P < 0.001). (D) The expression level of CARMN was significantly positively correlated with LVEF (r = 0.672, P < 0.001).